| Document Date: 1999-06-22 07:08:44
Open Document File Size: 76,24 KBShare Result on Facebook
City New York City / / Company PharmChem Laboratories / / Country United States / Jamaica / Greece / Costa Rica / / Currency USD / / Facility The Lindesmith Center / University of Mississippi / / IndustryTerm immune and reproductive systems / federal law / retail market / higher-potency products / higherpotency cannabis products / higher potency products / smokeable product / media reports / control / / MedicalCondition HIV infection / infertility / significant pulmonary abnormalities / leukemia / pulmonary risk / cancer / disease / seizures / epidemic / HIV-wasting syndrome / pulmonary risks / pulmonary function / emphysema / herpes infection / chronic effect / nausea / cognitive impairment / muscle spasm / pulmonary disease / seizure / vomiting / parasitic infection / chronic marijuana use / lung cancer / childhood leukemia / lung disease / chronic cough / AIDS / infectious diseases / pulmonary function testing / memory loss / police seizures / birth defects / chronic bronchitis / wheezing / chronic phlegm / / MedicalTreatment chemotherapy / drug therapy / / Organization UCLA / federal government / Lindesmith Center / FDA / National Institute on Drug Abuse / University of Mississippi / FACTS According to government / / Person John P. Morgan / / Position representative / / Product testosterone / Marinol / / ProvinceOrState Mississippi / / Technology drug delivery / chemotherapy / /
SocialTag |
John P. Morgan and Lynn Zimmer Exposing Marijuana Myths: A Review of the Scientific Evidence1